Product image of Nobabelle Daily (Ethinylestradiol, Gestodene) supplied by GNH India

Nobabelle Daily

Active Ingredient:
Ethinylestradiol, Gestodene
Origin:
EU

Nobabelle Daily (Ethinylestradiol, Gestodene)

Ethinylestradiol and Gestodene, the active ingredients in Nobabelle Daily, are a combined oral contraceptive presented as an oral tablet for oral use. It is indicated for prevention of pregnancy in women of reproductive age.

GNH India supplies Nobabelle Daily as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Egis Pharmaceuticals Plc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nobabelle Daily, a combined oral contraceptive, is indicated for prevention of pregnancy by suppressing ovulation and altering cervical mucus.

  • Contraception: prevents pregnancy in women of reproductive age.
  • Menstrual cycle regulation: helps to regularize menstrual bleeding patterns.
  • Acne management: reduces acne lesions associated with androgen excess.

How It Works

  • Ethinylestradiol and Gestodene bind to estrogen and progestogen receptors, respectively, providing negative feedback to the hypothalamic‑pituitary axis. This suppresses the secretion of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), preventing follicular development and ovulation. The progestogen component also thickens cervical mucus and induces endometrial changes that reduce the likelihood of fertilisation and implantation.

Side Effects

Nobabelle Daily may cause a range of adverse reactions, which are generally classified by frequency.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: transient tension‑type headaches.
  • Breast tenderness: temporary swelling or discomfort.
  • Spotting: irregular breakthrough bleeding.
  • Mood changes: irritability or mild depressive symptoms.
  • Weight gain: modest increase in body weight.

Serious or Rare Side Effects

  • Deep vein thrombosis: clot formation in deep veins.
  • Pulmonary embolism: blockage of pulmonary arteries.
  • Stroke: cerebrovascular accident, especially in high‑risk women.
  • Myocardial infarction: heart attack due to coronary occlusion.
  • Severe hypertension: sudden rise in blood pressure.
  • Liver tumor: benign hepatic adenoma in rare cases.

Precautions & Warnings

Before prescribing Nobabelle Daily, clinicians should consider several precautionary measures.

  • Assess cardiovascular risk: evaluate history of thromboembolic events.
  • Screen for smoking status: avoid use in women over 35 who smoke.
  • Review hepatic function: contraindicated in severe liver disease.
  • Consider migraine history: caution with migraine with aura.
  • Monitor blood pressure: check regularly during therapy.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Nobabelle Daily can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Antiepileptic enzyme inducers: carbamazepine, phenytoin, rifampicin – reduce contraceptive effectiveness.
  • Antiretroviral protease inhibitors: ritonavir – may increase hormone levels and risk of side effects.
  • St. John’s wort: herbal inducer – lowers efficacy of the hormonal components.

Moderate Interactions (Monitor Closely)

  • Antibiotics: broad‑spectrum tetracyclines – possible reduced contraceptive effect.
  • Antifungals: itraconazole – may increase hormone concentrations.
  • Diuretics: thiazides – may elevate blood pressure, requiring monitoring.

Frequently Asked Questions

Nobabelle Daily is a combined oral contraceptive indicated for the prevention of pregnancy in women of reproductive age. By inhibiting ovulation and altering cervical mucus, it provides reliable birth control when taken as prescribed.

Ethinylestradiol (an estrogen) and Gestodene (a progestogen) act on the hypothalamic‑pituitary‑ovarian axis. They suppress luteinizing hormone and follicle‑stimulating hormone release, preventing follicular maturation and ovulation. The progestogen also thickens cervical mucus and changes the endometrium, reducing the chance of fertilisation and implantation.

The dosing regimen for Nobabelle Daily is determined by the prescribing healthcare professional. Typically, one tablet is taken orally each day at the same time, but the exact schedule and any missed‑dose instructions are provided by the prescriber.

Nobabelle Daily is contraindicated during pregnancy because it is intended to prevent conception. Women who become pregnant should discontinue use and seek medical advice. Limited data exist for breastfeeding; clinicians should weigh benefits against potential risks before prescribing to nursing mothers.

To order Nobabelle Daily, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nobabelle Daily contains Ethinylestradiol and Gestodene, a low‑dose progestogen that offers a favorable bleeding profile and reduced androgenic activity compared with some older formulations. Its efficacy and safety are comparable to other second‑generation combined oral contraceptives, while its specific hormone balance may influence side‑effect tolerability.

Store Nobabelle Daily at ambient temperature, below 25 °C (77 °F). Keep the tablets in the original blister pack, protect them from moisture, heat and direct sunlight, and keep them out of reach of children.

Nobabelle Daily is taken orally, usually with water, once daily at the same time each day. It is a fixed‑dose combination tablet, and adherence to a daily schedule is essential for maintaining contraceptive effectiveness.

Serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, severe hypertension and rare hepatic tumors. These events are more likely in women with pre‑existing cardiovascular risk factors, smoking habits, or certain genetic predispositions.

Women with a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or those who are pregnant should avoid Nobabelle Daily. It is also contraindicated in smokers over 35 years of age and in individuals with migraine with aura.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.